JP2004504808A5 - - Google Patents

Download PDF

Info

Publication number
JP2004504808A5
JP2004504808A5 JP2001570749A JP2001570749A JP2004504808A5 JP 2004504808 A5 JP2004504808 A5 JP 2004504808A5 JP 2001570749 A JP2001570749 A JP 2001570749A JP 2001570749 A JP2001570749 A JP 2001570749A JP 2004504808 A5 JP2004504808 A5 JP 2004504808A5
Authority
JP
Japan
Prior art keywords
sequences
seq
polynucleotide
nos
identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001570749A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004504808A (ja
Filing date
Publication date
Priority claimed from US09/570,737 external-priority patent/US7202342B1/en
Priority claimed from US09/593,793 external-priority patent/US7517952B1/en
Priority claimed from US09/636,215 external-priority patent/US6620922B1/en
Priority claimed from US09/651,236 external-priority patent/US6818751B1/en
Priority claimed from US09/657,279 external-priority patent/US6894146B1/en
Priority claimed from US09/679,426 external-priority patent/US6759515B1/en
Priority claimed from US09/685,166 external-priority patent/US6630305B1/en
Application filed filed Critical
Priority claimed from PCT/US2001/009919 external-priority patent/WO2001073032A2/en
Publication of JP2004504808A publication Critical patent/JP2004504808A/ja
Publication of JP2004504808A5 publication Critical patent/JP2004504808A5/ja
Pending legal-status Critical Current

Links

JP2001570749A 2000-03-27 2001-03-27 前立腺癌の治療及び診断のための組成物及び方法 Pending JP2004504808A (ja)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US53685700A 2000-03-27 2000-03-27
US56810000A 2000-05-09 2000-05-09
US09/570,737 US7202342B1 (en) 1999-11-12 2000-05-12 Compositions and methods for the therapy and diagnosis of prostate cancer
US09/593,793 US7517952B1 (en) 1997-02-25 2000-06-13 Compositions and methods for the therapy and diagnosis of prostate cancer
US60578300A 2000-06-27 2000-06-27
US09/636,215 US6620922B1 (en) 1997-02-25 2000-08-09 Compositions and methods for the therapy and diagnosis of prostate cancer
US09/651,236 US6818751B1 (en) 1997-08-01 2000-08-29 Compositions and methods for the therapy and diagnosis of prostate cancer
US09/657,279 US6894146B1 (en) 1997-02-25 2000-09-06 Compositions and methods for the therapy and diagnosis of prostate cancer
US09/679,426 US6759515B1 (en) 1997-02-25 2000-10-02 Compositions and methods for the therapy and diagnosis of prostate cancer
US09/685,166 US6630305B1 (en) 1999-11-12 2000-10-10 Compositions and methods for the therapy and diagnosis of prostate cancer
US70972900A 2000-11-09 2000-11-09
PCT/US2001/009919 WO2001073032A2 (en) 2000-03-27 2001-03-27 Compositions and methods for the therapy and diagnosis of prostate cancer

Publications (2)

Publication Number Publication Date
JP2004504808A JP2004504808A (ja) 2004-02-19
JP2004504808A5 true JP2004504808A5 (enExample) 2008-05-15

Family

ID=27582800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001570749A Pending JP2004504808A (ja) 2000-03-27 2001-03-27 前立腺癌の治療及び診断のための組成物及び方法

Country Status (5)

Country Link
EP (1) EP1311673A2 (enExample)
JP (1) JP2004504808A (enExample)
AU (1) AU2001249549A1 (enExample)
CA (1) CA2403909A1 (enExample)
WO (1) WO2001073032A2 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
AU7019498A (en) 1997-04-10 1998-10-30 Diagnocure Inc. Pca3, pca3 genes, and methods of use
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
AU757698C (en) 1998-06-01 2004-04-08 Agensys, Inc. Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
US7037667B1 (en) 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
ES2260059T3 (es) 1999-09-29 2006-11-01 Diagnocure Inc. Rna mensajero del pca3 en tejidos benignos y malignos de prostata.
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US7208280B2 (en) 1999-10-05 2007-04-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
DK1517913T3 (da) * 1999-10-07 2007-06-18 Corixa Corp En Mycobacterium tuberculosis-kodende sekvens til ekspression af heterologe proteiner
DE60139963D1 (de) 2000-06-20 2009-10-29 Corixa Corp Fusionsproteine aus mycobakterium tuberculosis
EP2339035A1 (en) 2000-12-07 2011-06-29 Novartis Vaccines and Diagnostics, Inc. Endogenous retroviruses up-regulated in prostate cancer
EP2280030A3 (en) 2001-04-10 2011-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
CA2446788A1 (en) * 2001-05-09 2002-11-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
CA2447564A1 (en) * 2001-05-15 2002-11-21 Agensys, Inc. Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
US6897024B2 (en) 2001-05-31 2005-05-24 Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
US7229774B2 (en) 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
US7332290B2 (en) 2001-08-02 2008-02-19 The Regents Of The University Of Michigan Dectection of AMACR cancer markers in urine
US7700293B2 (en) 2001-08-02 2010-04-20 The Regents Of The University Of Michigan Expression profile of prostate cancer
AU2002336446B2 (en) 2001-09-06 2008-03-06 Agensys, Inc. Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
EP1474516B1 (en) 2002-01-25 2013-03-27 The Regents of The University of California Methods of modulating cold sensory perception
DK1511768T3 (da) * 2002-06-11 2007-08-20 Glaxosmithkline Biolog Sa Immunogene sammensætninger
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
AU2004209578A1 (en) 2003-02-07 2004-08-19 Diagnocure Inc. Method to detect prostate cancer in a sample
NZ550816A (en) 2004-04-22 2009-12-24 Agensys Inc Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
JP4969444B2 (ja) * 2005-06-14 2012-07-04 ディナベック株式会社 抗体の作製方法
ES2494843T3 (es) 2005-09-19 2014-09-16 Janssen Diagnostics, Llc Métodos y materiales para identificar el origen de un carcinoma de origen primario desconocido
US7622573B2 (en) * 2006-01-17 2009-11-24 Biolex, Inc. Expression control elements from the lemnaceae family
WO2007100568A2 (en) * 2006-02-24 2007-09-07 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services T cell receptors and related materials and methods of use
US7820174B2 (en) 2006-02-24 2010-10-26 The United States Of America As Represented By The Department Of Health And Human Services T cell receptors and related materials and methods of use
AU2007308792B2 (en) 2006-10-27 2013-01-24 Genentech, Inc. Antibodies and immunoconjugates and uses therefor
GB201513921D0 (en) * 2015-08-05 2015-09-23 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
SG11201909218RA (en) 2017-04-03 2019-11-28 Hoffmann La Roche Antibodies binding to steap-1
WO2024052922A1 (en) * 2022-09-11 2024-03-14 Yeda Research And Development Co. Ltd. Anti-klk4 antibodies and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100340610B1 (ko) * 1997-02-19 2002-06-12 야마모토 카즈모토 분해성 피복 필름으로 피복된 입상 비료 및 이의 제조 방법
US20030185830A1 (en) * 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
ES2248891T3 (es) * 1997-02-25 2006-03-16 Corixa Corporation Compuestos para inmunodiagnostico de cancer de prostata y metodos para su uso.
JP2002520054A (ja) * 1998-07-14 2002-07-09 コリクサ コーポレイション 前立腺癌の治療及び診断のための組成物及び方法
AU7994200A (en) * 1999-10-04 2001-05-10 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
EP1230364A2 (en) * 1999-11-12 2002-08-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO2001051633A2 (en) * 2000-01-14 2001-07-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
CA2446788A1 (en) * 2001-05-09 2002-11-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer

Similar Documents

Publication Publication Date Title
JP2004512022A5 (enExample)
Miura et al. Molecular cloning of nucleobindin, a novel DNA-binding protein that contains both a signal peptide and a leucine zipper structure
FR2772047B1 (fr) Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
RU2743016C2 (ru) Улучшение иммуногенности пептида l2 впч
JP2008538183A5 (enExample)
JP2009022296A (ja) 髄膜炎菌種の細菌に特異的なｄｎａおよび蛋白質またはペプチド、それらの取得方法およびそれらの生物学的応用
WO2001021810B1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
CA2332570A1 (en) Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
JP2006515749A5 (enExample)
JP5926194B2 (ja) Ｆｅｃｖ及びｆｉｐｖを区別する為の手段及び方法
JP2008508859A5 (enExample)
JP2010532657A5 (enExample)
JP2006515749A (ja) 前立腺癌の治療および診断のための組成物および方法
JP2002531522A5 (enExample)
TW210355B (enExample)
JP2017500883A (ja) 癌とｃｎｓの疾患の将来の進行のための初期マーカーおよび癌治療および予防のための標的としてのｈｃｂｉ配列
JP2007513604A (ja) 新規エンテロウイルス、ワクチン、医薬および診断キット
JP2001521744A5 (enExample)
JP2002512005A5 (enExample)
JP2010517544A5 (enExample)
WO2000018783B1 (en) Mammaglobin, a secreted mammary-specific breast cancer protein
EP3535412B1 (en) Phage-based detection of borreliosis and means therfor.
WO1991014779A1 (fr) Diagnostic du virus de l'hepatite
CA2232237A1 (en) Reagents and methods useful for detecting diseases of the breast
CA2190359A1 (en) Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection